MedPharm, a global leader in topical and transdermal contract drug development and manufacturing, announced the appointment ...

PCI asks institutions to submit SIF for academic session 2027-28 by November 30: Gireesh Babu, New Delhi Friday, November 6, ...

ANI Pharma announces offer to acquire Egetis Therapeutics, expanding the scope and scale of its rare disease business: Princeton, New Jersey Friday, November 6, 2026, 09:00 Hrs [I ...

Evommune inks agreement to in-license EVO570, a potential best-in-class oral VAV1 molecular glue degrader, from Hinova Pharma: Palo Alto, California Friday, November 6, 2026, 14:0 ...

Enveric Biosciences announces results from qEEG study of its lead candidate, EB-003: Cambridge, Massachusetts Friday, November 6, 2026, 18:00 Hrs [IST] Enveric Biosciences (Enveri ...

AstraZeneca Pharma India in Q2 clocks 30% growth with revenues at Rs. 729.1 crore, net profit at Rs. 62.33 crore: Our Bureau, Bengaluru Friday, November 6, 2026, 14:15 Hrs [IST] A ...

IML, MNLU Mumbai sign MoU to strengthen healthcare law education and research: Our Bureau, Mumbai The Institute of Medicine & Law (IML) a ...

Acepodia begins patient dosing in phase 1 trial of ACE723, a novel dual-payload antibody-drug conjugate: Alameda, California Acepodia, a ...

Our Bureau, Mumbai Friday, November 6, 2026, 13:40 Hrs [IST] Hester Biosciences Limited, one of India's leading animal health companie ...

Paras Healthcare Limited, a clinical specialty led hospital platform and one of the largest healthcare providers in North India, Bihar and Jharkhand, announced its unaudited consolidated financial ...

Glenmark Pharmaceuticals Ltd, a research led, global pharmaceutical company, announced its financial results for the second quarter ended September 30, 2026. Consolidated revenue for Q2 FY27 was Rs.

China NMPA grants priority review status to Akeso’s ivonescimab to treat locally advanced or metastatic biliary tract cancer: Hong Kong ...